Загрузка...
Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy
As immunotherapy assumes a central role in the management of many cancers, ongoing work is directed at understanding whether immune-based treatments will be successful in patients with glioblastoma (GBM). Despite several large studies conducted in the last several years, there remain no FDA-approved...
Сохранить в:
| Опубликовано в: : | Neuro Oncol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7686464/ https://ncbi.nlm.nih.gov/pubmed/32615600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa154 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|